Brochure
30 Sep 2022

Get the Australian Advantage

PDF 1.3 MB

The Australian Government is committed to promoting research and development by offering tax incentives and a favourable regulatory and business environment. By choosing Mayne Contract Services, you may be eligible to take advantage of these benefits, and our proven experience in generating intellectual property can accelerate your program’s patent protection goals.

Content provided by our supplier

Mayne Pharma

  • AU
  • 2022
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
Clinical Research
Contract Manufacturer
Intermediates Manufacturer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

Other Content from Mayne Pharma (1)